Viewing Study NCT00379847



Ignite Creation Date: 2024-05-05 @ 5:03 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00379847
Status: COMPLETED
Last Update Posted: 2014-05-02
First Post: 2006-09-21

Brief Title: An Open-Label Study of YM087 Conivaptan in Patients With Euvolemic or Hypervolemic Hyponatremia
Sponsor: Cumberland Pharmaceuticals
Organization: Cumberland Pharmaceuticals

Study Overview

Official Title: A 4-day Open-Label Multicenter Phase 3b Study of IV YM087 in Patients With Euvolemic or Hypervolemic Hyponatremia
Status: COMPLETED
Status Verified Date: 2014-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion The population studied will include patients with euvolemic or hypervolemic hyponatremia
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None